José González

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Miguel Á. Sanz, Pau Montesinos, Chelo Rayón et al. · Blood · 2010 · 335 citations · Full text

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Pau Montesinos, Chelo Rayón, Edo Vellenga et al. · Blood · 2010 · 135 citations · Full text

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-<i>Trans</i>-Retinoic Acid and Anthracycline-Based Chemotherapy

Pau Montesinos, José D. González, José González et al. · Journal of Clinical Oncology · 2010 · 72 citations · Full text

Acetylator polymorphism in human colorectal carcinoma.

J. M. Ladero, José González, J. Benítez et al. · PubMed · 1991 · 68 citations

Tumor Biology, Gastrointestinal Oncology, Medicine +12

Vascular enumeration as a significant prognosticator for invasive breast carcinoma.

María Jesús Fernández‐Aceñero, José González, M. Gallego et al. · Journal of Clinical Oncology · 1998 · 40 citations